Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, Daniela Vandini, Simone Barocci, Serena Benedetti, Eugenio Carlotti, Loris Zamai
Topics & Concepts
Downregulation and upregulationRenin–angiotensin systemReceptorAngiotensin-converting enzyme 2InflammationAngiotensin IIMedicineBiologyPharmacologyImmunologyCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseBiochemistryBlood pressureInfectious disease (medical specialty)GeneCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchInflammasome and immune disorders